Risk factor anaylysis of perioperative visual loss
Risk factor anaylysis of perioperative visual loss
批准号:
9388049
负责人:
STEVEN ROTH
金额:
$25.19万
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-09-30 至 2019-08-31
关键词:
AdultAgingAmericanAnemiaAnimalsAtherosclerosisBlindnessCardiac Surgery proceduresCaringCarotid StenosisCase SeriesCase StudyCase-Control StudiesChronicClinical ResearchColloidsComplicationCoronary Artery BypassCortical BlindnessDataData CollectionDatabasesDevelopmentDiabetes MellitusDiabetic RetinopathyDiagnosticDiseaseEconomic BurdenEmbolismEmotionalEyeEye diseasesFemaleFoundationsGlaucomaGoalsHeadHealthcareHemodilutionHemorrhageHumanHypertensionHypotensionIncidenceIndividualInjuryInpatientsInstitutionInsuranceInterventionIntervention StudiesIschemic Optic NeuropathyLifeLiquid substanceLiteratureLitigationMacular degenerationMedicalMedical EconomicsMedicare claimMissionModelingNatural HistoryObesityOdds RatioOperative Surgical ProceduresOptic NervePatient riskPatientsPerioperativePerioperative CarePositioning AttributePostoperative PeriodPreventionPrevention strategyProceduresProductivityRecording of previous eventsRegistriesReportingResearchResuscitationRetinaRetinalRiskRisk FactorsSamplingSeriesShapesSleep Apnea SyndromesSpinal FusionSpine surgeryStatistical ModelsStrokeTestingThrombocytopeniaUnited StatesValidationVasoconstrictor AgentsVertebral columnVision DisordersVisual impairmentaortic valveartery occlusionbaseclinically relevantcostcrystalloiddata modelinghigh riskindexinginnovationmalemiddle agenoveloperationpredictive modelingpreventprotective effectsex
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Perioperative visual loss (POVL) is a devastating complication, with no known treatment or prevention,
most commonly due to ischemic optic neuropathy (ION), or retinal arterial occlusion (RAO). The highest inci-
dence is associated with two of the most commonly performed inpatient surgical procedures in the United
States, spinal fusion, and cardiac surgery. The medical and economic burden of sudden, unexpected visual
loss is considerable; the emotional toll is immeasurable. It is imperative to understand the risk factors for POVL
in order to develop means to prevent these blinding complications.
There also exists here a unique opportunity to study the natural history and risk factors for perioperative
and spontaneous eye diseases that are among the most common causes of sudden adult vision loss. A most
pressing problem in POVL is predicting the high risk individual. Using the National Inpatient Sample, the pro-
ject will examine postulated risk factors for POVL, and construct a predictive risk model based on these factors
(Aim 1). The risk model will be externally validated using a large commercial insurance database (Aim 2). The
central hypothesis is that the presence of specific patient factors, and specific surgical factors, can predict the
risk of developing POVL.
Aim 1 will study risk factors and develop a predictive model for perioperative visual loss (POVL) in spinal
fusion and cardiac surgery using the NIS, with the following specific hypotheses based on the literature and
preliminary data:
1) Perioperative RAO and ION are associated with pre-existing abnormalities of the retina and/or optic nerve;
2) Carotid stenosis and specific forms of stroke increase risk of POVL; 3) Specific surgical factors are associ-
ated with POVL, including valvular heart surgery, and extent of fusions in spine surgery; 4) Female sex signifi-
cantly decreases risk of POVL.
Aim 2 will externally validate the predictive model from Aim 1 using Optum. We will test the hypothesis
that combinations of patient specific and surgical factors are synergistic in defining risk level, such that the ma-
jority of POVL incidents are predictable a priori.
The research fits the specific goals of this RFA for 2o analysis of existing data to generate new hypotheses.
Innovation includes: 1) the new concept relating pre-existing ophthalmic disease to POVL, 2) using diagnostic
and procedural data, and statistical modeling to build a risk profile index, and 3) cross-validation with another
database. In addition to direct clinical relevance of both the risk factor determination and the risk model, the
translational significance of both is the high likelihood of resulting changes in the care of surgical patients, and
development of prevention strategies. The underlying research significance is that the studies will set the
groundwork to enable vertical advancement of the field into mechanisms of injury.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mesenchymal stem cell extracellular vesicles for ischemic retinal damage
-
批准号:10707009
-
项目类别:
-
资助金额:$48.03万
-
财政年份:2022
-
负责人:STEVEN ROTH
-
依托单位:
VRC: Engineered extracellular vesicles for mild TBI-induced retinal injury
-
批准号:10598277
-
项目类别:
-
资助金额:$33.76万
-
财政年份:2022
-
负责人:STEVEN ROTH
-
依托单位:
Mesenchymal stem cell extracellular vesicles for ischemic retinal damage
-
批准号:10843511
-
项目类别:
-
资助金额:$5.16万
-
财政年份:2022
-
负责人:STEVEN ROTH
-
依托单位:
VRC: Engineered extracellular vesicles for mild TBI-induced retinal injury
-
批准号:10688145
-
项目类别:
-
资助金额:$31.76万
-
财政年份:2022
-
负责人:STEVEN ROTH
-
依托单位:
Mesenchymal stem cell extracellular vesicles for ischemic retinal damage
-
批准号:10766045
-
项目类别:
-
资助金额:$1.72万
-
财政年份:2022
-
负责人:STEVEN ROTH
-
依托单位:
Novel Cell Free Therapy for Glaucoma
-
批准号:10076404
-
项目类别:
-
资助金额:$3.24万
-
财政年份:2019
-
负责人:STEVEN ROTH
-
依托单位:
ADENOSINE AND RETINAL ISCHEMIA
-
批准号:6384388
-
项目类别:
-
资助金额:$20.0万
-
财政年份:1994
-
负责人:STEVEN ROTH
-
依托单位:
The Role of Adenosine in Retinal Ischemia
-
批准号:7811729
-
项目类别:
-
资助金额:$17.42万
-
财政年份:1994
-
负责人:STEVEN ROTH
-
依托单位:
The Role of Adenosine in Retinal Ischemia
-
批准号:7385926
-
项目类别:
-
资助金额:$36.52万
-
财政年份:1994
-
负责人:STEVEN ROTH
-
依托单位:
The Role of Adenosine in Retinal Ischemia
-
批准号:6801809
-
项目类别:
-
资助金额:$38.13万
-
财政年份:1994
-
负责人:STEVEN ROTH
-
依托单位:
ADENOSINE AND RETINAL ISCHEMIA
-
批准号:6179808
-
项目类别:
-
资助金额:$25.45万
-
财政年份:1994
-
负责人:STEVEN ROTH
-
依托单位:
The Role of Adenosine in Retinal Ischemia
-
批准号:7198014
-
项目类别:
-
资助金额:$37.26万
-
财政年份:1994
-
负责人:STEVEN ROTH
-
依托单位:
The Role of Adenosine in Retinal Ischemia
-
批准号:7582380
-
项目类别:
-
资助金额:$37.26万
-
财政年份:1994
-
负责人:STEVEN ROTH
-
依托单位:
The Role of Adenosine in Retinal Ischemia
-
批准号:8404012
-
项目类别:
-
资助金额:$37.05万
-
财政年份:1994
-
负责人:STEVEN ROTH
-
依托单位:
The Role of Adenosine in Retinal Ischemia
-
批准号:7103046
-
项目类别:
-
资助金额:$38.29万
-
财政年份:1994
-
负责人:STEVEN ROTH
-
依托单位:
The Role of Adenosine in Retinal Ischemia
-
批准号:8597423
-
项目类别:
-
资助金额:$38.22万
-
财政年份:1994
-
负责人:STEVEN ROTH
-
依托单位:
ADENOSINE AND RETINAL ISCHEMIA
-
批准号:2164154
-
项目类别:
-
资助金额:$20.21万
-
财政年份:1994
-
负责人:STEVEN ROTH
-
依托单位:
ADENOSINE AND RETINAL ISCHEMIA
-
批准号:2164155
-
项目类别:
-
资助金额:$26.96万
-
财政年份:1994
-
负责人:STEVEN ROTH
-
依托单位:
ADENOSINE AND RETINAL ISCHEMIA
-
批准号:2696491
-
项目类别:
-
资助金额:$26.18万
-
财政年份:1994
-
负责人:STEVEN ROTH
-
依托单位:
The Role of Adenosine in Retinal Ischemia
-
批准号:6547443
-
项目类别:
-
资助金额:$36.55万
-
财政年份:1994
-
负责人:STEVEN ROTH
-
依托单位:
海外基金